Global Immunotherapy Drugs Market

  • Report Code : VMI235896
  • Pages : 142
  • Published On : Dec 2018
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 3,950
Multi User License: US$ 4,750
Corporate User License: US$ 6,750
Market Overview:
The global Immunotherapy Drugsmarket was valued at USD 108.39 billion in 2016 and is projected to reach USD 338.54 billion by 2025, growing at a CAGR of 13.49% from 2017 to 2025.
Immunotherapy is in high demand due to increased preference for minimal invasive treatment methods and advantages provided by the treatment type. The market is expected to grow during the forecast period.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Increasing Adoption of Targeted Therapy
1.2 Emergence of Biosimilars
1.3 Increasing Demand for Mabs
1.4 High Prevalence Rate of Lifestyle Diseases
1.5 Fast Track and Orphan Drug Designations
2. Market Restraints
2.1 High Cost of Immunotherapy Treatment
2.2 High Attrition Rate in the Product Development Cycle

Market Segmentation:
1. By Therapy Area:
1.1 Cancer
1.2 Autoimmune and Inflammatory Diseases
1.3 Infectious Diseases
1.4 Other Therapy Areas

2. By End User:
2.1 Hospitals
2.2 Clinics
2.3 Other End Users

3. By Type of Drug:
3.1 Monoclonal Antibodies
3.2 Adult Vaccines
3.2.1 Preventive Vaccines
3.2.2 Therapeutic Vaccines
3.3 Checkpoint Inhibitors
3.4 Interferons Alpha & Beta
3.5 Interleukins
3.6 Other Drugs

4. By Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. F. Hoffmann-La Roche AG
2. Merck & Co., Inc.
3. Novartis International AG
4. Johnson & Johnson (A Parent Company of Janssen Biotech, Inc.)
5. Glaxosmithkline PLC
6. Amgen Inc.
7. Abbvie
8. Astrazeneca
9. Bristol-Myers Squibb
10. ELI Lilly and Company
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Immunotherapy Drugsmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team. 
1 INTRODUCTION OF GLOBAL IMMUNOTHERAPY DRUGSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL IMMUNOTHERAPY DRUGSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY THERAPY AREA:
5.1 Overview
5.2 Cancer
5.3 Autoimmune and Inflammatory Diseases
5.4 Infectious Diseases
5.5 Other Therapy Areas

6 GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY END USER:
6.1 Overview
6.2 Hospitals
6.3 Clinics
6.4 Other End Users

7 GLOBAL IMMUNOTHERAPY DRUGS MARKET, BY TYPE OF DRUG:
7.1 Overview
7.2 Monoclonal Antibodies
7.3 Adult Vaccines
7.3.1 Preventive Vaccines
7.3.2 Therapeutic Vaccines
7.4 Checkpoint Inhibitors
7.5 Interferons Alpha & Beta
7.6 Interleukins
7.7 Other Drugs

8 GLOBAL IMMUNOTHERAPY DRUGSMARKET, BY GEOGRAPHY
8.1 Overview
8.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

9 GLOBAL IMMUNOTHERAPY DRUGSMARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 F. Hoffmann-La Roche AG
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Merck & Co., Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Novartis International AG
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Johnson & Johnson (A Parent Company of Janssen Biotech, Inc.)
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Glaxosmithkline PLC
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Amgen Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Abbvie
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Astrazeneca
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Bristol-Myers Squibb
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Development

10.10 ELI Lilly and Company
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Development

11 Appendix
11.1 Related Reports

mRNA Vaccine Drugs Development Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The mRNA Vaccine Drugs Development Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...

Asia Pacific Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Photodynamic Therapy Market is on the brink of significant growth, driven by increasing cancer prevalence, advancements in Photodynamic Therapy technology, and rising awareness about minimally invasive treatment options. Market research indicates a robus...

Europe Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Photodynamic Therapy Market is poised for substantial growth in the coming decade, propelled by increasing cancer incidence, advancements in photodynamic therapy technology, and heightened awareness of minimally invasive treatments. Market research forecasts t...

North America Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Photodynamic Therapy Market is projected to witness substantial growth in the coming decade, driven by the rising prevalence of cancer, advancements in Photodynamic Therapy technology, and increasing awareness of minimally invasive treatments. Market re...

Global Photodynamic Therapy Market Size, Share, Trends & Analysis by Product Type (Photodynamic Therapy Devices, Photosensitizer Drugs), by Application (Active Keratosis, Cancer, Psoriasis, Acne, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Photodynamic Therapy Market is poised to experience substantial growth in the coming decade, driven by the rising prevalence of cancer and other chronic diseases, advancements in PDT technology, and increasing awareness of minimally invasive treatment options....

Drugs Produced by Fermentation Engineering Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Drugs Produced by Fermentation Engineering Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Drugs of Abuse Testing Products Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Drugs of Abuse Testing Products Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...

Small Molecule Targeted Drugs for Allergic Diseases Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Small Molecule Targeted Drugs for Allergic Diseases Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, compet...

Rare Disease Enzyme Replacement Therapy Drugs Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Rare Disease Enzyme Replacement Therapy Drugs Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...

Anticancer Drugs Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Anticancer Drugs Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/play...